|
Market Closed -
Nasdaq
20:00:00 30/10/2026 GMT
|
5-day change | 1st Jan Change | ||
| 15.19 USD | -0.52% |
|
+9.83% | - |
| 09-20 | Attovia Therapeutics, Inc.(NasdaqGM:ATTO) added to S&P TMI Index | CI |
| 09-16 | Attovia Therapeutics, Inc. Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-16-2026 10:00 AM |
Evolution of the Average Target: Attovia Therapeutics, Inc.
Evolution of the Target Price: Attovia Therapeutics, Inc.
Changes in Analyst Recommendations: Attovia Therapeutics, Inc.
0910bb6b6e.qcG16ke3W-QKph3aXCysLDJixdXbpYkNcHK-75i_Juw.2IzQmHX4L69MxVmuA0T1eVUJqa21yKRKJBPpruuNdqL-goa_AuIIgCfRLQ~033db840e11a7f187328484d3c102f79
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
 | - | +177.81% | ||||
| +42.48% | |||||
| +24.46% | |||||
| +8.88% | |||||
| +15.87% | |||||
| +17.86% | |||||
| +35.3% | |||||
| +1.94% | |||||
| +41.27% | |||||
| +72.28% | |||||
| Average | +43.81% | |||||
| Weighted average by Cap. | +27.34% |
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
15.19USD
Average target price
42.20USD
Spread / Average Target
+177.81%
High Price Target
52.00USD
Spread / Highest target
+242.33%
Low Price Target
30.00USD
Spread / Lowest Target
+97.50%
Analyst Consensus Detail
Consensus revision (last 18 months)
- Stock Market
- Stocks
- ATTO Stock
- Consensus Attovia Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
